Catheter stabilization devices are developed to lower the risk for phlebitis, catheter migration and dislodgement, and to reduce catheter-related complications. Use of catheter stabilization devices also reduces the chances and risk of needlestick injuries.

These devices are primarily used during cardiovascular surgeries, general surgeries, cancer treatment procedures and others. The recent past has witnessed use of advance stabilization devices by hospitals, ambulatory surgical centers and other healthcare facilities to reduce the rate of catheter-related complications during surgical procedures.

Catheter Stabilization Devices Market Drivers

In the recent past, key players involved in manufacturing of catheter stabilization devices have launched various novel catheter stabilization devices in market. The launch of such novel devices is expected to support and drive catheter stabilization devices market growth over the forecast period.

For instance, in 2016, B. Braun Medical Inc. launched its novel STEADYCare extension set with Wedge catheter stabilizer. This new device helps to reduce catheter movement in the vessel, limits the patient connector’s skin contact, maintains the catheter insertion angle, and improves stabilization with reduced catheter-related complications. In July 2018, 3M Korea launched PICC/CVC securement device+CHG Dressing package system. This new catheter anchoring system reduces the risk of bloodstream infection.

The guidelines published by various government organization emphasizing on the use of catheter stabilization devices in order to reduce catheter-related infections is expected to increase demand for these devices and fuel the global catheter stabilization devices market growth.

For instance, in 2011, Centers for Disease Control and Prevention issued guidelines for healthcare professionals, who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital and clinics. According to the guideline, catheter stabilization devices must be used to reduce the risk of infection for intravascular catheters.

Furthermore, high prevalence of cardiovascular and lifestyle diseases and growing number of clinical surgeries is expected to rise demand for catheter stabilization devices in hospitals and other healthcare facilities.

For instance, according to World Health Organization (WHO), cardiovascular diseases (CVDs) are the largest cause of death around the world, approximately 17.7 million people died from CVDs in 2015, representing 31% of death worldwide, in which around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. According to World Health Organization (WHO) 2012, around 266.2 to 359.5 million operations were performed worldwide and the ratio is increasing significantly.

Catheter Stabilization Devices Market Regional Analysis

North America catheter stabilization devices market is expected to show a significant growth in near future, owing to presence of key players in the region and launch of novel products by them in North America. For instance, in 2013, Tangent Medical (now part of ICU Medical, Inc.) launched its product, NovaCath Integrated IV Catheter System in the U.S. market. NovaCath offers an advanced catheter stabilization technology which meets the Centers for Disease Control and Prevention and Occupational Safety and Health Administration standards for IV catheter stabilization.

Europe catheter stabilization devices market is also expected to show good growth in the near future, owing to high prevalence of cardiovascular diseases which will rise demand for catheter stabilization devices. For instance, according to the data published by European Heart Network and European Society of Cardiology in 2012, cardiovascular diseases (CVD) every year causes over 4 million deaths in Europe and over 1.9 million deaths in the European Union (EU) and such incidents are increasing rapidly.

Asia Pacific catheter stabilization devices market is expected to show a drastic growth over the forecast period, owing to high prevalence of life threatening diseases such as cancer, and Heart diseases. High prevalence of such diseases is expected to increase demand for catheter stabilization device during its treatment. For instance, the data published by American Cancer Society in 2017 shows cancer as the leading cause of death in China, with 4.3 million new cancer cases and 2.8 million cancer deaths occurring each year.

Catheter Stabilization Devices Market Key Players

Key players operating in the global catheter stabilization devices market include B. Braun Melsungen AG, Baxter International, Inc., 3M Company, C. R. Bard, Inc., ICU Medical, Inc. Smith’s Group Plc., Merit Medical Systems, Inc., and others.

Catheter Stabilization Devices Market Taxonomy

The global catheter stabilization devices market is segmented on the basis of product type, application, end user, and region.

By Product Type